Kliniske studier for Gliom i Michigan
8 studier for Gliom søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
RekruttererFase 1/2
12 Months – 21 Years · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Henry Ford Cancer- Detroit, Detroit
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererFase 2
12 Months – 39 Years · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06838676Targeted Pediatric High-Grade Glioma Therapy
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererObservasjonsstudie
12 Months – 39 Years · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05839379SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Henry Ford Hospital, Detroit
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererFase 2
Alder 3 til 39 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05096481Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererFase 2
12 Months – 39 Years · Alle kjønn · Oppdatert 29. mai 2026 · NCT05843253Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
- Henry Ford Health System, Detroit
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 16. des. 2025 · NCT05686798Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.